Recent research from i-sense members at UCL seeks to understand whether currently available digital health technologies and online information related to HIV offers adequate emotional support.
In light of technology advances, a recent publication in Nature Microbiology, updates the current benchmark that describes the ideal diagnostic test, taking into consideration the need to achieve the Sustainable Devel
New research from i-sense members at UCL, in collaboration with the Africa Health Research Institute (AHRI), looks at ways data visualisation can help population surveillance sites better utilise and understand the large amounts of data they collect for disease surveillance.
A recent study, published in Journal of Virological Methods, suggests and evaluates a modification to a currently used lab-based diagnostic test for dengue. The improved test has shown it can reduce the likelihood of false negatives and increase identification of a specific type of the virus.
The combination of mobile devices with diagnostic tools offers new possibilities to test, track and treat infectious diseases as well as improve health systems, according to a new review published today in Nature.
On the 12 & 13 December, the Africa Health Research Institute (AHRI) hosted the m-Africa workshop in Durban. The project is a two-year Medical Research Council GCRF Foundation Award that started in April 2017. m-Africa has allowed researchers from University College London, Imperial College London, and AHRI to work together to evaluate the feasibility of introducing mobile phone-connected tools to improve access to HIV testing, as well as linkage to care, in KwaZulu-Natal.
With the help of a Patient Public Involvement Starter Grant from the NIHR University College London Hospitals Biomedical Research Centre, Dr Harriet Gliddon, an i-sense Postdoc in the McKendry group, held a consultation with people who are living with HIV to understand how i-sense research developing a rapid test for HIV viral load could be used by individuals in the home and link them to digital healthcare systems.
A new review from i-sense members, published in AIDS, looks at the last 20 years of research around diagnostics that use p24, an important protein in the detection of early stage HIV.
New research from the McKendry group at UCL, published in Digital Medicine, reports a pilot clinical study using a shear horizontal surface acoustic wave (SH-SAW) biosensors based on low-cost components found in smartphones to diagnose HIV in 133 patients.
As the NHS celebrates its 70th anniversary, i-sense Director, Professor Rachel McKendry, is helping to assess how new technologies including genomics, artificial intelligence and bionanotechnology, will shape the future of healthcare in the UK for decades to come.
